Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the detailed content, with a standard header/footer and a navigation bar indicating access is blocked.
    Difference
    21%
    Check dated 2026-09-19T19:26:23.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page displays an updated revision label from v3.6.5 to v3.6.6, representing a small maintenance update to the site's underlying version rather than a content change.
    Difference
    0.1%
    Check dated 2026-08-29T20:22:50.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5. This reflects a new build of the ClinicalTrials.gov page and does not indicate a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-08T18:48:00.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a software patch or update to the platform. This appears to be a routine version increment rather than a modification to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T11:39:06.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.2 to v3.6.3, indicating a new build/version of the page.
    Difference
    0.0%
    Check dated 2026-07-04T04:18:37.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.0 to v3.6.2, indicating a site version update with no changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-06-27T02:52:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.